The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $74.55

Today's change+1.11 +1.51%
Updated August 22 4:02 PM EDT. Delayed by at least 15 minutes.
 

ResMed Inc

NYSE: RMD
Last

(U.S.) $74.55

Today's change+1.11 +1.51%
Updated August 22 4:02 PM EDT. Delayed by at least 15 minutes.

ResMed Inc crosses above 20-day moving average

ResMed Inc closed up sharply Tuesday, rallying (U.S.)$1.11 or 1.51% to (U.S.)$74.55 and crossing above its 20-day moving average. Over the last five days, shares have gained 2.91% and 20.15% year to date. Shares have underperformed the S&P 500 by 5.53% during the last year.

Key company metrics

  • Open(U.S.) $73.52
  • Previous close(U.S.) $73.44
  • High(U.S.) $74.85
  • Low(U.S.) $73.49
  • Bid / Ask-- / --
  • YTD % change+20.15%
  • Volume501,052
  • Average volume (10-day)554,195
  • Average volume (1-month)1,852,725
  • Average volume (3-month)1,104,881
  • 52-week range(U.S.) $56.59 to (U.S.) $79.63
  • Beta0.82
  • Trailing P/E31.02×
  • P/E 1 year forward24.25×
  • Forward PEG2.39×
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield1.88%
  • Trailing EPS(U.S.) $2.40
Updated August 22 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.22%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2017Q3/2017Q2/2017Q1/2017
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue557514530465
Total other revenue--------
Total revenue557514530465
Gross profit324300309269
Total cost of revenue233214221196
Total operating expense429407434371
Selling / general / administrative148138139129
Research & development37353834
Depreciation / amortization12111212
Interest expense (income), net operating--------
Unusual expense (income)0823--
Other operating expenses, total--------
Operating income1271079794
Interest income (expense), net non-operating-28------
Gain (loss) on sale of assets--------
Other--------
Income before tax1221089693
Income after tax102887776
Income tax, total20201917
Net income102887776
Total adjustments to net income--------
Net income before extra. items102887776
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items102887776
Inc. avail. to common incl. extra. items102887776
Diluted net income102887776
Dilution adjustment------0
Diluted weighted average shares143143142142
Diluted EPS excluding extraordinary itemsvalue per share0.710.620.540.54
Dividends per sharevalue per share0.330.330.330.33
Diluted normalized EPSvalue per share0.710.660.670.54